Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 15Recruiting 9Unknown 5Terminated 5Active not recruiting 5Withdrawn 1

Sponsor Class

OTHER 8NETWORK 1

Study Type

Interventional 9

Sponsor

Cancer Type

Thoracic 5Tumor-Agnostic 1Plasma cell 1Lymphoid 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Rare Tumor 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Crizotinib × Clear all
NCT06563999 2026-04-21

NUMER

Sun Yat-sen University

Phase 2 Recruiting
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting
720 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT04423185 2025-02-11

PLATFORM Study of Precision Medicine for Rare Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
770 enrolled

Rare Tumor

NCT04322890 2024-10-22

PIKACHU

Hunan Province Tumor Hospital

Phase 2 Recruiting
6,000 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05014464 2024-09-20

ATPase

Hunan Province Tumor Hospital

Phase 2 Recruiting
90 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04084717 2024-07-16

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

University Health Network, Toronto

Phase 2 Recruiting
50 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04322578 2024-06-04

CONFIRM

Hunan Province Tumor Hospital

Phase 2 Recruiting
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02925234 2024-01-24

DRUP

The Netherlands Cancer Institute

Phase 2 Recruiting
1,550 enrolled
Tumor-Agnostic

Neoplasms

NCT05725200 2023-02-21

EVIDENT

Oslo University Hospital

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡